The Japan Hypertension Evaluation with Angiotensin 2 Antagonist Losartan Therapy

The Japan Hypertension Evaluation with Angiotensin 2 Antagonist Losartan Therapy - J-HEALTH study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006149

Enrollment

30000

Registered

2011-08-11

Start date

2000-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertension (Only patients who were not receiving antihypertensive drugs for at least 1 month prior to the study)

Exclusion criteria

Exclusion criteria: Patients with a history of losartan treatment at any period were excluded from the study

Design outcomes

Primary

Measure	Time frame
Stroke, MI	—

Countries

Japan

Contacts

Public ContactKeisuke Mori

MSD KK Marketing division

keisuke.mori@merck.com03-6272-1388

Outcome results